CADILA HEALTHCARE Surges by 6%; BSE HEALTHCARE Index Down 0.0%
March 17, 2020 03:26 PM

CADILA HEALTHCARE share price has zoomed 6% and is presently trading at Rs 264.

Meanwhile, the BSE HEALTHCARE Index is at 12,548 .

Among the top Gainers in the BSE HEALTHCARE Index today are CADILA HEALTHCARE (up 5.9%) and THYROCARE TECHNOLOGIES (up 8.7%).

PIRAMAL ENTERPRISES (down 0.2%) and CAPLIN POINT (down 0.5%) are among the top losers today.

Over the last one year, CADILA HEALTHCARE has moved down from Rs 339 to Rs 264, registering a loss of Rs 75 (down 22.2%).

On the other hand, the BSE HEALTHCARE has moved down from 14,216 to 12,548, loss of 1,668 points (down 14.4%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 102.6%), J.B.CHEMICALS (up 66.3%) and IPCA LABS (up 50.7%).

What About the Benchmark Indices?

The BSE Sensex is at 32,048 (down 2.7%).

The top gainers among the BSE Sensex stocks today are HUL (up 3.3%), HERO MOTOCORP (up 3.1%) and ASIAN PAINTS (up 2.8%). Other gainers include POWER GRID (up 2.0%) and MARUTI SUZUKI (up 1.7%). The most traded stocks in the BSE Sensex are ITC and SUN PHARMA.

In the meantime, NSE Nifty is at 9,404 (down 2.8%). The top gainers in the NSE Nifty include YES BANK (up 59.6%), EICHER MOTOR (up 3.5%) and HUL (up 2.9%). Other gainers include MARUTI SUZUKI (up 2.6%) and HERO MOTOCORP (up 2.5%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,095 to 32,048, registering a loss of 6,047 points (down 19.79%).

CADILA HEALTHCARE Financial Update...

CADILA HEALTHCARE net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 5 billion a year ago. Net Sales rose 1.7% to Rs 36.4 billion during the period as against Rs 35.8 billion in October-December 2018.

For the year ended March 2019, CADILA HEALTHCARE reported 4.8% increase in net profit to Rs 18.5 billion compared to net profit of Rs 17.7 billion during FY18.

Revenue of the company grew 10.1% to Rs 132 billion during FY19.

The current Price to earnings ratio of CADILA HEALTHCARE, based on rolling 12 month earnings, stands at 21.8x.